Woodland Park, N.J., April 13, 2017 --- Effective June 1, 2017, or as contracts allow, Solvay’s global business unit, Technology Solutions, will implement an across-the-board price increase of 10 percent for MAX HT® scale inhibitor products.

This price increase is necessary due to higher operations and maintenance costs required to sustain Solvay’s production capabilities and, in particular, a requirement to cease deferment of critical component replacement.

Solvay remains committed to leveraging its deep understanding of chemistry and global supply chain to help customers achieve their goals, now and in the future.     Solvay is a multi-specialty chemical company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers in diverse global end markets. Its products and solutions are used in planes, cars, smart and medical devices, batteries, in mineral and oil extraction, among many other applications promoting sustainability. Its lightweighting materials enhance cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 27,000 employees in 58 countries. Net sales were € 10.9 billion in 2016, with 90% from activities where Solvay ranks among the world’s top 3 leaders. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program.

Contact us

Ron Sausa

Solvay Technology Solutions Global Marketing Communications Manager